124 related articles for article (PubMed ID: 7502851)
1. Cholera toxin-mediated cellular immune responses against ovalbumin administered orally.
Bowen JC; Reddy RM; Rouse BT
Adv Exp Med Biol; 1995; 371B():1531-3. PubMed ID: 7502851
[No Abstract] [Full Text] [Related]
2. Mucosal suppression by oral pre-treatment with ovalbumin and its conversion into stimulation when ovalbumin was conjugated to cholera toxin or its B subunit.
van der Heijden PJ; Stok W; Bianchi AT
Adv Exp Med Biol; 1995; 371B():1251-5. PubMed ID: 7502794
[No Abstract] [Full Text] [Related]
3. Effect of cholera toxin and its B subunit on intestinal permeability for ovalbumin.
Pierre PG; Mbella EG; Vaerman JP
Adv Exp Med Biol; 1995; 371B():1519-21. PubMed ID: 7502848
[No Abstract] [Full Text] [Related]
4. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo.
Porgador A; Staats HF; Faiola B; Gilboa E; Palker TJ
J Immunol; 1997 Jan; 158(2):834-41. PubMed ID: 8993001
[TBL] [Abstract][Full Text] [Related]
5. Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens.
Bowen JC; Nair SK; Reddy R; Rouse BT
Immunology; 1994 Mar; 81(3):338-42. PubMed ID: 8206507
[TBL] [Abstract][Full Text] [Related]
6. Modulating dendritic cells to optimize mucosal immunization protocols.
Williamson E; Westrich GM; Viney JL
J Immunol; 1999 Oct; 163(7):3668-75. PubMed ID: 10490961
[TBL] [Abstract][Full Text] [Related]
7. CD11c(high )dendritic cells are essential for activation of CD4+ T cells and generation of specific antibodies following mucosal immunization.
Fahlén-Yrlid L; Gustafsson T; Westlund J; Holmberg A; Strömbeck A; Blomquist M; MacPherson GG; Holmgren J; Yrlid U
J Immunol; 2009 Oct; 183(8):5032-41. PubMed ID: 19786541
[TBL] [Abstract][Full Text] [Related]
8. Successful priming and tolerization of T cells to orally administered antigens in B-cell-deficient mice.
Hashimoto A; Yamada H; Matsuzaki G; Nomoto K
Cell Immunol; 2001 Jan; 207(1):36-40. PubMed ID: 11161451
[TBL] [Abstract][Full Text] [Related]
9. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization.
de Geus B; Dol-Bosman M; Scholten JW; Stok W; Bianchi A
Vaccine; 1997 Jul; 15(10):1110-3. PubMed ID: 9269054
[TBL] [Abstract][Full Text] [Related]
10. Presence of antigen-specific long-term memory cells in systemic lymphoid tissues as well as locally in the gut lamina propria following oral immunization with cholera toxin adjuvant.
Vajdy M; Lycke N
Adv Exp Med Biol; 1995; 371B():1495-500. PubMed ID: 7502844
[No Abstract] [Full Text] [Related]
11. Oral tolerance to ovalbumin in mice: effect of some parameters on the induction and persistence of the suppression of systemic IgE and IgG antibody responses.
Moreau MC; Coste M; Gaboriau V; Dubuquoy C
Adv Exp Med Biol; 1995; 371B():1229-34. PubMed ID: 7502789
[No Abstract] [Full Text] [Related]
12. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection.
Cuburu N; Kweon MN; Hervouet C; Cha HR; Pang YY; Holmgren J; Stadler K; Schiller JT; Anjuère F; Czerkinsky C
J Immunol; 2009 Dec; 183(12):7851-9. PubMed ID: 19933861
[TBL] [Abstract][Full Text] [Related]
13. Effect of sublingual administration with a native or denatured protein allergen and adjuvant CpG oligodeoxynucleotides or cholera toxin on systemic T(H)2 immune responses and mucosal immunity in mice.
Huang CF; Wang CC; Wu TC; Chu CH; Peng HJ
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):443-52. PubMed ID: 18051215
[TBL] [Abstract][Full Text] [Related]
14. The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.
Bregenholt S; Wang M; Wolfe T; Hughes A; Baerentzen L; Dyrberg T; von Herrath MG; Petersen JS
Scand J Immunol; 2003 May; 57(5):432-8. PubMed ID: 12753499
[TBL] [Abstract][Full Text] [Related]
15. Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin.
Tamura S; Shoji Y; Hasiguchi K; Aizawa C; Kurata T
Vaccine; 1994 Oct; 12(13):1238-40. PubMed ID: 7839730
[TBL] [Abstract][Full Text] [Related]
16. Oral immunogenicity of the plant proteinase bromelain.
Hale LP; Fitzhugh DJ; Staats HF
Int Immunopharmacol; 2006 Dec; 6(13-14):2038-46. PubMed ID: 17161360
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract.
Israf DA; Lajis NH; Somchit MN; Sulaiman MR
Life Sci; 2004 Jun; 75(4):397-406. PubMed ID: 15147827
[TBL] [Abstract][Full Text] [Related]
18. Evidence for early aging in the mucosal immune system.
Koga T; McGhee JR; Kato H; Kato R; Kiyono H; Fujihashi K
J Immunol; 2000 Nov; 165(9):5352-9. PubMed ID: 11046071
[TBL] [Abstract][Full Text] [Related]
19. Cholera and pertussis toxins, but not forskolin or LT-B, adjuvant IgA antibody responses to orally administered antigen.
Wilson AD; Robinson A; Irons L; Stokes CR; Bland PW
Adv Exp Med Biol; 1995; 371B():1523-6. PubMed ID: 7502849
[No Abstract] [Full Text] [Related]
20. Cholera toxin increases T lymphocyte responses to unrelated antigens.
Hornquist E; Lycke N
Adv Exp Med Biol; 1995; 371B():1507-12. PubMed ID: 7502846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
